JP2007526891A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007526891A5 JP2007526891A5 JP2006518502A JP2006518502A JP2007526891A5 JP 2007526891 A5 JP2007526891 A5 JP 2007526891A5 JP 2006518502 A JP2006518502 A JP 2006518502A JP 2006518502 A JP2006518502 A JP 2006518502A JP 2007526891 A5 JP2007526891 A5 JP 2007526891A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- fzd10
- seq
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48619503P | 2003-07-11 | 2003-07-11 | |
| US60/486,195 | 2003-07-11 | ||
| PCT/JP2004/002144 WO2005004912A1 (en) | 2003-07-11 | 2004-02-24 | Method for treating synovial sarcoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007526891A JP2007526891A (ja) | 2007-09-20 |
| JP2007526891A5 true JP2007526891A5 (https=) | 2007-12-06 |
| JP4691626B2 JP4691626B2 (ja) | 2011-06-01 |
Family
ID=34062116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006518502A Expired - Lifetime JP4691626B2 (ja) | 2003-07-11 | 2004-02-24 | 滑膜肉腫の治療方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1648506B1 (https=) |
| JP (1) | JP4691626B2 (https=) |
| AT (1) | ATE545658T1 (https=) |
| ES (1) | ES2381841T3 (https=) |
| WO (1) | WO2005004912A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7803370B2 (en) | 2002-08-30 | 2010-09-28 | Oncotherapy Science, Inc. | Method for treating synovial sarcoma |
| AU2003271175A1 (en) | 2002-10-11 | 2004-05-04 | Masahiro Abe | Cell death-inducing agent |
| CA2611726C (en) | 2005-06-10 | 2017-07-11 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical compositions containing sc(fv)2 |
| KR101367544B1 (ko) | 2005-06-10 | 2014-02-26 | 추가이 세이야쿠 가부시키가이샤 | 메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용 |
| US7723477B2 (en) | 2005-10-31 | 2010-05-25 | Oncomed Pharmaceuticals, Inc. | Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth |
| CA2628221A1 (en) * | 2005-10-31 | 2007-05-10 | Oncomed Pharmaceuticals, Inc. | Anti-frizzled receptor antibodies for treating cancer |
| EP2386577A3 (en) | 2006-06-21 | 2012-05-02 | Oncotherapy Science, Inc. | Tumor-targeting monoclonal antibodies to FZD10 and uses thereof |
| WO2008061020A2 (en) * | 2006-11-14 | 2008-05-22 | Novartis Ag | Methods of treating, diagnosing or detecting cancer |
| CL2008000719A1 (es) * | 2007-03-12 | 2008-09-05 | Univ Tokushima Chugai Seiyaku | Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a |
| SG190568A1 (en) | 2008-09-26 | 2013-06-28 | Oncomed Pharm Inc | Frizzled-binding agents and uses thereof |
| TWI535445B (zh) | 2010-01-12 | 2016-06-01 | 安可美德藥物股份有限公司 | Ｗｎｔ拮抗劑及治療和篩選方法 |
| CA2794674A1 (en) | 2010-04-01 | 2011-10-06 | Oncomed Pharmaceuticals, Inc. | Frizzled-binding agents and uses thereof |
| EP3281640A1 (en) | 2011-06-17 | 2018-02-14 | President and Fellows of Harvard College | Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer |
| WO2013025446A2 (en) * | 2011-08-12 | 2013-02-21 | Omeros Corporation | Anti-fzd10 monoclonal antibodies and methods for their use |
| WO2013157410A1 (ja) * | 2012-04-17 | 2013-10-24 | Hoya株式会社 | Ｆｚｄ１０結合性ペプチド |
| AU2013334790A1 (en) | 2012-10-23 | 2015-04-30 | Oncomed Pharmaceuticals, Inc. | Methods of treating neuroendocrine tumors using Wnt pathway-binding agents |
| AU2014212081A1 (en) | 2013-02-04 | 2015-08-13 | Oncomed Pharmaceuticals, Inc. | Methods and monitoring of treatment with a Wnt pathway inhibitor |
| US9168300B2 (en) | 2013-03-14 | 2015-10-27 | Oncomed Pharmaceuticals, Inc. | MET-binding agents and uses thereof |
| TWI762516B (zh) | 2016-10-06 | 2022-05-01 | 日商腫瘤療法 科學股份有限公司 | 針對ｆｚｄ１０之單株抗體及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| GB9414580D0 (en) * | 1994-07-19 | 1994-09-07 | Cancer Res Campaign Tech | Materials and methods relating to the diagnosis of synovial sarcomas |
| US5994098A (en) * | 1997-06-02 | 1999-11-30 | Smithkline Beecham Corporation | Human 7-TM receptor similar to murine frizzled-6 gene |
| EP0943684A3 (en) * | 1998-03-10 | 2002-01-23 | Smithkline Beecham Plc | Frizzled-like polypeptides and polynucleotides |
| GB9819681D0 (en) * | 1998-09-09 | 1998-11-04 | Smithkline Beecham Plc | Novel compounds |
| CA2433742A1 (en) * | 2001-01-11 | 2002-07-18 | Curagen Corporation | Proteins and nucleic acids encoding same |
| US20030044409A1 (en) * | 2001-05-01 | 2003-03-06 | Carson Dennis A. | Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens |
-
2004
- 2004-02-24 JP JP2006518502A patent/JP4691626B2/ja not_active Expired - Lifetime
- 2004-02-24 ES ES04713982T patent/ES2381841T3/es not_active Expired - Lifetime
- 2004-02-24 EP EP04713982A patent/EP1648506B1/en not_active Expired - Lifetime
- 2004-02-24 AT AT04713982T patent/ATE545658T1/de active
- 2004-02-24 WO PCT/JP2004/002144 patent/WO2005004912A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007526891A5 (https=) | ||
| JP2009541204A5 (https=) | ||
| JP2005528099A5 (https=) | ||
| JP2010516708A5 (https=) | ||
| JP2018198596A5 (https=) | ||
| JP2007527406A5 (https=) | ||
| JP2020526478A5 (https=) | ||
| US20100036101A1 (en) | Antibodies against non functional p2x7 receptor | |
| US20200291134A1 (en) | Methods and compositions for the generation and use of conformation-specific antibodies | |
| JP2011526785A5 (https=) | ||
| JP2011528561A5 (https=) | ||
| US20150111250A1 (en) | Methods and compositions for modulating tumor cell activity | |
| JP2009517057A5 (https=) | ||
| RU2009101788A (ru) | Направленные на опухоль моноклональные антитела против fzd10 и их применение | |
| JP2012012402A5 (https=) | ||
| JP2018504105A5 (https=) | ||
| NZ597067A (en) | Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer | |
| RU2014149332A (ru) | Антитела против клаудина 18.2 для диагностики рака | |
| JP2019504032A5 (https=) | ||
| RU2009120052A (ru) | Композиции и способы связывания сфингозин-1-фосфата | |
| JP2010523096A5 (https=) | ||
| RU2010136940A (ru) | Антитела против альфа5-бета1 и их применение | |
| JP2015506912A5 (https=) | ||
| JP2011526249A5 (https=) | ||
| TW201713700A (zh) | 抗ｇｌｙｐｉｃａｎ-３抗體及其用於診斷及治療癌症之用途 |